Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 August 2023 | Story Lacea Loader

All academic activities on the campuses of the University of the Free State (UFS) will resume face-to-face on Monday 7 August 2023.

This decision by the university’s executive management comes after campus-wide protests on 2 August 2023, and the subsequent decision to continue the academic programme online until 4 August 2023.

The university can confirm that a large number of UFS-registered students funded by the National Student Financial Aid Scheme (NSFAS) who have been excluded from payment, have received their allowances on Friday 4 August 2023. The university is aware that a small number of students have not yet onboarded successfully with eZaga – an online digital banking service tasked with disbursing direct payments to NSFAS beneficiaries. These students have been requested to urgently onboard successfully with eZaga in order to receive their allowances.

On a sectoral level, the university would also like to confirm that a statement has been issued by Universities South Africa (USAf) in which NSFAS and the Department of Higher Education, Science and Innovation are, among others, requested to urgently resolve the matter of the direct payment of allowances to students. The UFS fully supports the statement and is hopeful that an amicable and urgent solution to the matter can be found.

Protection Services and the South African Police Service remain on high alert and are monitoring the situation on the campuses closely. The necessary security measures are in place to ensure the safety of students and staff.

Prof Francis Petersen, Vice-Chancellor and Principal, will address our staff and students on 8 August 2023 about last week’s protest action. Please monitor the communication platforms for more information on this important engagement session.

message from Prof Francis Petersen, Vice-Chancellor and Principal, to staff and students about last week’s protest was also shared on 3 August 2023.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept